Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03002623
Title CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

thyroid gland papillary carcinoma

tall cell variant papillary carcinoma

thyroid gland Hurthle cell carcinoma

thyroid gland cancer

Therapies

CUDC-907

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
National Institutes of Health Clinical Center Bethesda Maryland 20892 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field